2006 annual financial data
Summit Therapeutics 2006 Operating margin
Direct answer
Operating margin was -423.82%.
Operating income was -8,595,000 GBP and net income was -5,924,000 GBP.
Operating cash flow was -5,959,082 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,028,000 GBP
- Operating income
- -8,595,000 GBP
- Net income
- -5,924,000 GBP
- Operating cash flow
- -5,959,082 GBP